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Abstract 
Objectives: This study was conducted to investigate the occurrence of 
VRE among non–hospitalized individuals and to evaluate the public 
awareness of the globally escalating issue of antibiotics resistance.  
Methods: One hundred non-hospitalized individuals were interviewed 
and stool sample was collected from each during the period between 
January and June, 2006. Isolation of Enterococci was performed 
according to standard method. Each Enterococcus isolate was 
subjected to vancomycin susceptibility test. Results were statistically 
analyzed using SPSS software 
Results: We obtained 84 enterococcal isolates out of one hundred 
stool sample, 32.1% of them were resistant to vancomycin. No 
significant difference between male and female, level of education, 
hospitalization, age and Enterococcus carriage or VRE. Higher 
percentage of VRE was observed among those who were previously 
admitted to hospitals.  
Conclusions: A high percentage of Vancomycin resistance was 
demonstrated among Enterococcus spp. isolated from non-
hospitalized individuals. No single risk factor could be attributed to 
acquiring VRE.  Therefore, we may conclude that the general 
population is equally exposed. 
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 نيميقملا ريغ صاخشلأا يف نيسيموكنافلل ةمواقملا ةيوعملا تاروكملا
نيطسلف ,ةزغ ةنيدم يف ىفشتسملا يف 
صخلم 
فادهلأا نسةسسموكناافل ةةمواقملا ةيوعملا تاروكملا دوجو ةبسن نم ققحتلا فدهب ةساردلا هذه تيرجأ :
 ةةساردلا ةةةسع ىدةل يعولا ىدم ةفرعم ىلا ةساردلا فدهت و .يفاشملا يف نسمسقملا رسغ صاخشلأا نسب
.ةيوسحلا تاداضمفل ايرستكبلا ةمواقم ةفكشمل ةبسةلاب 
ةقيرطلا رياةةي نسةب اةم ةرتالا يف يفاشملا يف نسمسقم رسغ عمتجملا نم صخش ةئام عم ةفباقم ءارجإ مت :
  اةةع وةةسنوي ىةةلإ2006 تةةعمجو  ةةةيوعملا تاروةةكملا عمةةع و تاةةةسعلا ةةةعاره مةةت .مهةةةم هارةةب تاةةةسع
 اسئاصحإ جئاتةلا لسفحت مت و .نسسسموكناافل اهتسساسح ىدم ةساردل تلامعلا صحف مت و ةسساسقلا قرطلاب
 جمانرب  ادختسابSPSS. 
  ااااتنلا ىةةةفع عوةةةصحلا مةةةت :84  نةةةم ةةةةلمع100  ةةةةمواقملا ةةةةيوعملا تاروةةةكملا تفكةةةش هارةةةب ةةةةةسع
افل هتبسن ام نسسسموكنا32.1% لمح ةبسن نسب ةيوةعم ةللاد تاذ قورف ةسئاصحلإا تلاسفحتلا رهظت مل .
 .رةمعفل ةبةسةلاب رةملأا رلذةك و يفاةشملا يةف ةةماالإا  مسةفعتلا ىوتسم وأ ثانلإا و روكذلا نسب بوركسملا
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ةاأ نيذةلا نسب بوركسملا لمح نم يفعا ةبسن ةساردلا ترهظأ دقف رلذ نم مغرلا ىفع يفاةشملا يةف اوما
 .اهسف اومسقي مل نيذلا نم 
 اتنتاسلاا ةةيوعملا تاروةكملا تلامةع نسةب نسةسسموكناافل ةةمواقملا نةم ةةسلاع ةبةسن ةةساردلا ترةهظأ :
 ةةيوعملا تاروةكملا باةستكا سةبر ةةساردلا عطتةست مةل .يفاةشملا يف نسمسقم رسغ صاخشأ نم ةلومعملا
 ددحم رطخ لماع يأب نسسسموكناافل ةمواقملا اوةنوكي امبر ناكسلا لمجم نأ ىلإ صوفخلا نكمي هسفع و
.ةجردلا ساةب نسضرعم 
ةيحاتفم تاملكةمغ  ةيوسحلا تاداضملا ةمواقم  نسسسموكناافل ةمواقملا ةيوعملا تاروكملا : 
 
Introduction 
Species of the genus Enterococcus are the most common 
Gram-positive cocci in the intestinal tract and the 4th most common 
nosocomial source of bacteremia in the United States1. Two clinically 
relevant species, Enterococcus faecalis and Enterococcus faecium, 
have been shown to acquire resistance to glycopeptides and account 
for a majority of enterococcal infections2. Enterococci occur almost 
everywhere, including soil, food, water, plants, animals, birds, and 
insects. They inhabit humans and other animal's gastrointestinal tract 
and the female genital tract 3. 
Detection of Vancomycin Resistant Enterococci (VRE) 
colonization can be accomplished by culturing the organism on a 
variety of selective and differential media, most commonly, bile 
esculin azide with 6 or 8 μg/mL of vancomycin (BEAV) agar4. 
Enterococcus species are aerobic gram positive cocci that are 
found commonly as normal flora in the gastrointestinal tract. 
Enterococci have been shown to colonize on skin surfaces and in the 
genitourinary tract as well. Although there are at least 17 species of 
the genus Enterococcus, the most common enterococcal species 
related to infection and bacteremia are E. faecium (85%–95%) and E. 
faecalis (5%– 10%)5. 
Numerous infections have been attributed to enterococci, 
including urinary tract infections, intra-abdominal abscesses, 
bacteremia, and endocarditis. Less commonly, meningitis and 
osteoarticular infections are attributed to enterococci6. 
Vancomycin resistance in enterococci has been superimposed 
on the increasing prevalence of high-level enterococcal resistance to 
penicillin and aminoglycosides, making it difficult to treat patients 
with infections caused by these microorganisms. The potential also 
exists for VRE to transfer vancomycin resistance genes to other gram-
positive organisms, including Staphylococci. There have been a few 
documented cases of intermediate resistance to vancomycin in 
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methicillin-resistant Staphylococcus aureus (MRSA). With MRSA 
already a substantial problem for long-term care facilities (LTCFs), 
MRSA with vancomycin resistance would be devastating7.This study 
is considered as the first study in Gaza strip to investigate the 
occurrence of VRE among non–hospitalized individuals. We also 
attempted to assess the public awareness on antibiotic resistance issue 
and to examine the possible risk factors of acquiring VRE. 
 
Material and Methods 
One hundred, randomly selected healthy subjects (36 females 
and 64 males) were interviewed and either stool or rectal swab 
samples were collected. The objective of the research was explained 
and an informed consent was taken from all subjects. Subjects were 
asked to fill out a brief questionnaire and submit a stool sample or 
rectal swab, which was either collected by the participants themselves 
or by the investigator.  The questionnaire consisted of both open and 
close ended questions dealing with personal, socioeconomic data, and 
attitude toward self-diagnosis and treatment of illness with antibiotics.   
The study started Jan 15 and lasted till June 6, 2006. 
Rectal swabs or 1 g of stool specimen were placed in tubes 
containing 5 ml of Brain Heart Infusion Broth (BHIB) and transported 
to the laboratory. Subcultures were made onto the surface of freshly 
prepared Slanetz & Bartley Agar (oxoid) and Bile Esculine Agar 
(HiMedia) with no antibiotics.  Plates were incubated at 37 C for 48-
72 hours.  Colonies growing on agar with morphologically resembling 
enterococci were primarily identified by Gram staining, catalase test 
and by growth in 6.5% NaCl broth8.   
Resistance to vancomycin was screened by the modified 
Kirby-Bauer disk diffusion assay.  An inoculum with a turbidity 
equivalent to that of a no. 1 McFarland standard and Mueller-Hinton 
agar (HiMedia, India) were used. Vancomycin disks (30 µg) were 
placed on the surface of the plate. The plates were read after 
incubation at 37 °C for 24 h. Zones of inhibition were interpreted 
according to the standard charts supplied with Vancomycin 
antibiotic9. 
Data obtained from microbiological investigation and from the 
questionnaire   survey   were uploaded   to (SPSS version 11) software 
and analyzed using cross tabulating & chi square test. 
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Results 
During the study period, 100 stool/rectal swab samples were collected 
from non-hospitalized individuals in Gaza city, 84 of them exhibited 
positive culture for Enterococci (table 1). No statistically significance 
difference between male and female enterococcal carriage. The same 
finding was observed with age.  
 
Table 1: Distribution of Enterococcus positive stool culture 
according to age and sex 
Stool culture 
for 
Enterococcus 
Age in years 
Total 1-16  17- 40  Over 40  
+ve -ve +ve -ve +ve -ve 
Male 19 3 7 1 6 0 36 
Female 21 2 20 6 11 4 64 
Total 40 5 27 7 17 4 100 
Total positive 40 27 17 84 
 
The 84 enterococcal isolates were tested against vancomycin 
and as shown in table 2, 32.1% of the total isolates proved to be 
resistant to vancomycin. Neither age (table 2) nor sex (figure 1) could 
be considered as a risk factor. 
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Figure 1: Distribution of VRE according to sex 
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     Table 2: Distribution of VRE according to age 
Age in  
years 
Enterococcus sensitivity to 
vancomycin Total 
Sensitive Resistant 
1-16  
25 
62.5% 
15 
37.5% 
40 
100% 
17-40 
19 
70.4% 
8 
29.6% 
27 
100% 
Over 40 
13 
76.5% 
4 
23.7% 
17 
100% 
Total 
57 
67.9% 
27 
32.1% 
84 
100% 
 
Several possible risk factors for acquiring VRE were 
investigated, however, none of them showed statistically significant 
correlation with VRE carriage. Table 3 summarizes the investigated 
risk factors and their corresponding P value as calculated by Chi 
square test. 
The 100 interviewed subjects answered several questions 
regarding their attitude to self diagnosis and self medication or 
malpractices. Although a high percentage (84%) was shown to carry 
Enterococcus in their intestinal tract and a considerable percentage 
(32.1%) were carrying the VRE, only few of them (10) admitted of 
not possessing any information about the risks of antibiotic misuse. 
All of the 10 are in the age group 1-16 (Table 4). 
 
Discussion 
Enterococci were found in 84% of intestinal tract of the study 
sample. This proportion of non hospitalized patients who carry 
enterococci is approximately similar to that found in previous studies, 
in which 80% of community carried these microorganisms10. 
VRE were isolated from 32.1% of the 100 individuals living in 
the community. Such high rates among non hospitalized individuals 
may be explained by the presence of risk factors for VRE acquisition, 
such as antimicrobial use, frequent and prolonged hospitalization and 
severity of underlying diseases. This finding is in disagreement with 
study in Hong Kong in which VRE were not isolated from either 
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healthy or hospitalized patients11 and a very low parentage (2%) was 
reported in the Netherlands10.   
 
Table 3: Possible risk factors for acquiring VRE 
Variables 
VSE  VRE  
 
P-
value 
N
o. 
% No. % 
Age 
1-16 
17-40 
Over 40 
25 
19 
13 
62.5 
70.4 
76.5 
15 
8 
4 
37.5 
29.6 
23.5 
0.554 
Sex 
 
Male 
Female 
19 
38 
59.4 
73.1 
13 
14 
40.6 
26.9 
0.144 
Residence 
City 
Village  
55 
2 
67.9 
66.7 
26 
1 
32.1 
33.3 
0.693 
work 
 
Student 
Housewife 
Employee 
Laborer 
No work 
23 
7 
4 
2 
21 
65.7 
77.8 
66.7 
66.7 
67.7 
12 
2 
2 
1 
10 
34.3 
22.2 
33.3 
33.3 
32.3 
0.975 
Level of  
education 
Pre-school 
Un-educated 
1-12 grade 
University 
12 
6 
33 
6 
70.6 
60.0 
70.2 
60.0 
5 
4 
14 
4 
29.4 
40.0 
29.8 
40.0 
0.863 
Admitted 
 to hospital 
yes 
no 
10 
47 
52.6 
72.3 
9 
18 
47.4 
27.7 
0.092 
Antibiotic 
consumed  
within the  
last 2 years 
yes 
no 
28 
29 
68.3 
67.4 
13 
14 
31.7 
32.6 
0.560 
Compliance  
with 
physician 
instruction 
yes 
no 
53 
4 
67.1 
80.0 
26 
1 
32.9 
20.0 
0.481 
Pre-mature 
cessation of 
 therapy 
yes 
no 
4 
53 
80 
67.1 
1 
26 
20.0 
32.9 
0.481 
P<0.05 is significant; P>0.05 is not significant 
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Table 4: Awareness of antimicrobial resistance among the study 
population 
Age in years 
Do you possess 
information about the 
risks of antibiotic 
misuse 
Total 
Yes No 
1-16 
35 
77.8% 
10 
22.2% 
45 
100% 
17-40 
34 
100% 
0 
0% 
34 
100% 
Over 40 
21 
100% 
0 
0% 
21 
100% 
Total 
90 
90% 
10 
10% 
100 
100% 
P= 0.01 
 
Although outbreaks of VRE have been reported in Europe, 
carriage rates are generally lower, with most workers reporting rates 
between 0.8% and 2%. Even though many patients had received 
antibiotics, it did not result in carriage of VRE, although receipt of 
antibiotics has been shown to be a risk factor by other workers11. 
In a Belgian study12 , 11 (28%) of 40 volunteers living in the 
community who were healthy, who were not health care workers, and 
who had not received antibiotics for at least 1 year were colonized 
with VRE. The results of North American studies performed in the 
Houston, Texas, metropolitan area, however, contrast with the 
European data, since VRE appeared to be absent from healthy people 
in Houston13. 
The presence of VRE in the stools of non-hospitalized 
individuals suggests that VRE form part of the normal human fecal 
flora or can be acquired in the community, as confirmed by several 
other studies12. A possible source of VRE could be the food chain, 
since VRE has been reported in the feces of farm animals and in 
animal product-based foodstuffs. The origin of the contamination of 
meat remains unknown, but it might occur during processing and 
packaging or through the intestinal flora of slaughtered animals12.  
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Some European investigators have raised the possibility that the 
glycopeptide avoparcin, which has been used as a food additive for 
growth enhancement in animals for nearly 20 years, might have 
selected VRE strains in animals14. The gastrointestinal tract is 
probably the major reservoir in humans, from which subsequent 
infection can eventually develop. This is in agreement with a report 
from New York City15.  Food has been proposed as a source of 
transmission16. Others have put forward pets and other domestic 
animals14. Furthermore, the use of antibiotics as feed additives for 
growth enhancement in animals may be associated with the 
emergence of VRE17. 
Some investigators, however, have cautioned against 
comparing the results of similar studies, since differences in 
methodology could, at least in part, explain the observed differences 
in isolation rates13. 
 
Conclusions and recommendations 
A high percentage of vancomycin resistant was demonstrated 
among Enterococcus spp. isolated from non-hospitalized individuals. 
No single risk factor could be attributed to acquiring VRE.  Therefore, 
we may conclude that the general populations may be equally 
exposed. It is recommended that further research to pinpoint the 
source/s of acquiring VRE should be conducted. Meantime, local 
hospitals should adapt strict infection control measure to prevent 
nosocomial infection. 
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